Federal contract award
HDTRA117C0070
PENICILLIN BINDING PROTEINS IGF::OT::IGF
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541711 |
| PSC | AD92 — OTHER DEFENSE - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $14.3M |
| Current contract value | $14.7M |
| Potential contract value / ceiling | $20.0M |
| Start date | Aug 28, 2017 |
| Current end date | Apr 30, 2022 |
| Potential end date | Oct 27, 2023 |
| Latest award activity | Apr 30, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 30, 2026 | P00013 | $0 | NEW PBP INHIBITORS IMPERVIOUS TO BETA-LACTAMASES |
| Feb 17, 2026 | P00012 | $-460.2K | NEW PBP INHIBITORS IMPERVIOUS TO BETA-LACTAMASES |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.